Evaluation of the Safety and Clinical Performance of the Connected Catheter Study

Exclusion Criteria

• •1\. Active symptomatic urinary tract infection, as defined in this clinical investigation plan (CIP)/protocol (subjects may receive the device after their UTI has been treated) 2. Significant risk profile or recent history of urethral stricture (e.g., stricture within past 90 days) 3. Significant risk profile or recent history of clinically significant (uncontrolled) autonomic dysreflexia 4. Significant intermittent urinary incontinence (between catheterizations) 5. Uninhibited bladder contractions and/or Vesicoureteral reflux that is not reliably controlled with medication or alternate therapy (e.g., Botox injection)
• •1. Active symptomatic urinary tract infection, as defined in this clinical investigation plan (CIP)/protocol (subjects may receive the device after their UTI has been treated)
• •2. Significant risk profile or recent history of urethral stricture (e.g., stricture within past 90 days)
• •3. Significant risk profile or recent history of clinically significant (uncontrolled) autonomic dysreflexia
• •4. Significant intermittent urinary incontinence (between catheterizations)
• •5. Uninhibited bladder contractions and/or Vesicoureteral reflux that is not reliably controlled with medication or alternate therapy (e.g., Botox injection)
• •6. Pre-existing urinary pathologies and/or morphological abnormalities of the lower urinary tract or bladder (assessed during in-depth medical screening, including cystoscopy and urine analysis)
• •1. Urinary tract inflammation or neoplasm
• •2. Urinary fistula
• •3. Bladder diverticulum (outpouching) \> 5cm in size
• •4. Chronic pyelonephritis (secondary to upper urinary tract infection(s) within past 6 months)
• •5. Impaired kidney function or renal failure
• •6. Active gross hematuria
• •7. Active urethritis
• •8. Bladder stones
• •7. Dependence on an electro-magnetic medical implant (e.g., cardiac pacemaker or implanted drug pump) or external device
• •8. Any unsuitable comorbidities as determined by the Principal Investigator or complications related to use of certain medications
• •9. Any physical or cognitive impairments that diminish the subject's ability to follow directions or otherwise safely use the Connected Catheter System
• •10. Catheter Assessment Tool screening yields unacceptable results
• •11. Vulnerable population such as inmates or developmentally delayed adults